ADORA2A and Alzheimer disease: Due to the A2A adenosine receptor’s synaptic roles in neuronal injury, neuroinflammation, astrocytes, and microglia, it has been suggested as a potential peripheral biomarker in AD cases and even a possible therapeutic target for these patients [31].